PROQR THERAPEUTICS EO-04 (0PQ) — Cash Flow Reinvestment Rate

Latest as of December 2023: 0.06x

PROQR THERAPEUTICS EO-04 (0PQ) has a Cash Flow Reinvestment Rate of 0.06x as of December 2023, reinvesting €1.37 Million (capex €1.37 Million ) from operating cash flow of €21.55 Million. Explore how much does PROQR THERAPEUTICS EO-04 reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.06x

(Capex + Investments) / Operating CF

Total Reinvested

€1.37 Million

Capex + Investments

Operating Cash Flow

€21.55 Million

EUR

Capital Expenditures

€1.37 Million

EUR

PROQR THERAPEUTICS EO-04 Cash Flow Reinvestment Rate (2023–2023)

Historical reinvestment intensity for PROQR THERAPEUTICS EO-04 across 1 annual periods. Also explore PROQR THERAPEUTICS EO-04 (0PQ) total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for PROQR THERAPEUTICS EO-04 (2023–2023)

Year-by-year capital reinvestment analysis for PROQR THERAPEUTICS EO-04. For live market cap and broader valuation context, see PROQR THERAPEUTICS EO-04 (0PQ) market capitalisation.

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change
2023	0.06x	€1.37 Million	€21.55 Million	€1.37 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow